CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease

Alzheimer’s disease (AD) is a rapidly growing disease that affects millions of people worldwide, therefore there is an urgent need for its early diagnosis and treatment. A huge amount of research studies are performed on possible accurate and reliable diagnostic biomarkers of AD. Due to its direct c...

Descripción completa

Detalles Bibliográficos
Autores principales: Papaliagkas, Vasileios, Kalinderi, Kallirhoe, Vareltzis, Patroklos, Moraitou, Despoina, Papamitsou, Theodora, Chatzidimitriou, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218948/
https://www.ncbi.nlm.nih.gov/pubmed/37240322
http://dx.doi.org/10.3390/ijms24108976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218948/
https://www.ncbi.nlm.nih.gov/pubmed/37240322
http://dx.doi.org/10.3390/ijms24108976

Ejemplares similares